Regent Peak Wealth Advisors LLC Sells 44 Shares of CME Group Inc. (NASDAQ:CME)

Regent Peak Wealth Advisors LLC lowered its holdings in CME Group Inc. (NASDAQ:CME) by 3.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,401 shares of the financial services provider’s stock after selling 44 shares during the quarter. Regent Peak Wealth Advisors LLC’s holdings in CME Group were worth $372,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of CME Group by 1.0% during the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider’s stock worth $7,952,273,000 after acquiring an additional 326,623 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of CME Group by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider’s stock worth $1,946,717,000 after acquiring an additional 104,697 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of CME Group by 89.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider’s stock worth $1,923,047,000 after acquiring an additional 3,921,278 shares in the last quarter. Norges Bank bought a new position in shares of CME Group during the 4th quarter worth approximately $1,107,389,000. Finally, FIL Ltd raised its stake in shares of CME Group by 1.5% during the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider’s stock worth $947,821,000 after acquiring an additional 61,908 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Down 0.2%

CME stock opened at $274.24 on Friday. The firm’s fifty day simple moving average is $271.69 and its 200-day simple moving average is $253.09. The company has a market capitalization of $98.82 billion, a P/E ratio of 28.36, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $290.79.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the prior year, the firm earned $2.50 EPS. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date is Monday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 50.30%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on CME shares. Piper Sandler boosted their price objective on shares of CME Group from $275.00 to $283.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 8th. Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target on the stock in a research note on Monday, March 10th. Oppenheimer upped their price target on shares of CME Group from $282.00 to $300.00 and gave the company an “outperform” rating in a research note on Wednesday. Morgan Stanley upped their price target on shares of CME Group from $301.00 to $304.00 and gave the company an “overweight” rating in a research note on Thursday, April 24th. Finally, UBS Group upped their price target on shares of CME Group from $290.00 to $305.00 and gave the company a “buy” rating in a research note on Friday, April 25th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $258.20.

Insider Buying and Selling

In other CME Group news, Director Daniel G. Kaye sold 500 shares of the company’s stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the transaction, the director now directly owns 3,668 shares in the company, valued at approximately $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $272.56, for a total transaction of $817,680.00. Following the transaction, the director now owns 5,400 shares of the company’s stock, valued at $1,471,824. This represents a 35.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 22,900 shares of company stock valued at $6,147,935. Corporate insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.